Numab
Matthias Brock is a highly experienced professional in the field of cell biology and pharmacology, currently serving as the Director and Group Leader at Numab Therapeutics AG since October 2016. Prior to this role, Matthias worked at UniversitätsSpital Zürich from July 2007 to September 2016 as a Wissenschaftlicher Mitarbeiter, where responsibilities included leading research in the Clinic for Pneumology, securing third-party funding, writing scientific articles, and supervising PhD and Master’s students. Matthias holds a Ph.D. in Molecular Medicine from the University of Zurich, obtained between 2008 and 2012, and a Diplom in Biochemistry from Leipzig University, completed in 2007.
This person is not in any offices
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.